The PDK3 gene helps control how cells turn sugar into energy by putting a brake on a key energy pathway. This gene plays an important role in keeping that balance steady, and if it does not work properly, nerve cells may not get energy in the way they need. Some people with variants in the PDK3 gene develop an inherited nerve condition in the Charcot-Marie-Tooth group. This can lead to slowly worsening foot weakness, balance problems, changes in walking, and later hand weakness.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or direct activities in the body. Some genes provide the instructions for producing proteins, which are the parts of cells that do the work. Others are mainly involved in regulating when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
PDK3Gene function
What if the gene works
The PDK3 gene helps cells control how they use sugar for energy by slowing a key step that sends fuel into the cell's energy centers. This helps match energy production to the body's needs.
Risk
What if the gene does not work
Variants in the PDK3 gene can cause an inherited peripheral nerve condition, usually Charcot-Marie-Tooth neuropathy, with weakness, foot shape changes, and reduced sensation; milder and more severe variants may affect how early symptoms start and how limiting they become.
Treatment
What does that mean for your treatment
No PDK3-specific treatment or drug selection approach is currently established in clinical guidelines. Care is based on a person’s symptoms rather than the PDK3 gene result. The PDK3 gene is being studied as a metabolic drug target, including in cancer and nerve disease research, but this has not yet changed routine treatment.
Conditions associated with PDK3
Gene function
What if the gene works
Your cells need the PDK3 gene to fine tune how they turn food into energy. Inside mitochondria, the parts of cells that make much of your energy, it helps control a key step linking sugar breakdown to the main energy pathway. When this system works smoothly, cells can adjust fuel use in a steady, flexible way.
The PDK3 gene makes a protein that adds a phosphate tag to the pyruvate dehydrogenase complex, a key energy enzyme in mitochondria. This acts like a brake, controlling how much fuel from sugar moves into the next stage of energy production.
By slowing that step when needed, the PDK3 gene helps cells balance the use of glucose with other energy sources. This is part of how the PDK3 gene supports mitochondrial energy production during daily changes in activity and food supply.
Inside mitochondria, the PDK3 gene helps keep energy processing flexible rather than fixed at one speed. This lets cells adjust to routine shifts in energy demand while using fuel in a more controlled way.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change gene function more substantially and may play a role in or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PDK3 gene usually make the enzyme too active or less able to switch off. This is how PDK3 gene variants affect enzyme activity: the altered protein adds too many phosphate tags to the pyruvate dehydrogenase complex, which reduces that complex’s activity inside mitochondria. Different variants can shift PDK3 activity by different amounts, and stronger gain-of-function changes are linked to earlier or more marked features in PDK3-related Charcot-Marie-Tooth neuropathy.
How variants are linked to conditions
Pathogenic variants in the PDK3 gene cause X-linked dominant Charcot-Marie-Tooth disease type 6, a rare condition affecting the peripheral nerves. In families with PDK3 gene variants linked to Charcot-Marie-Tooth disease, people may develop slowly progressive weakness, muscle thinning, or reduced feeling that often starts in the feet and legs and can later involve the hands. Because this is an X-linked condition, the pattern seen in relatives can differ between females and males.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal part of human biology in the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some instances, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is no broadly confirmed evidence that lifestyle or environmental factors specifically increase or reduce risk related to the PDK3 gene. In families with a disease-causing PDK3 change, sex can affect how likely symptoms are and how severe they become, because this gene is on the X chromosome.
Inheritance of PDK3 variants
PDK3-related neuropathy follows an X-linked dominant pattern, which is the key point in how variants of the PDK3 gene are inherited. A parent carrying a disease-causing variant in the PDK3 gene can pass it on to a child in each pregnancy. Mothers can pass the variant to sons or daughters, while fathers pass their X chromosome only to daughters, not to sons. This means all daughters of an affected father are expected to inherit the variant, and none of his sons do.
What does my PDK3 result mean for my family?
Changes in the PDK3 gene are linked to an inherited nerve condition that follows an X-linked pattern. This can mean close relatives on the same side of the family may also carry the variant or have symptoms, even if those symptoms are mild. Family implications differ for males and females, so the result can matter for siblings, children, and other blood relatives.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for PDK3 variants usually uses a blood or saliva sample, and the lab reads the DNA sequence of the PDK3 gene to look for changes. Testing may examine only this gene or include it in a larger nerve disease panel or exome test. Results are then interpreted alongside symptoms and family history.
When should I consider getting a genetic test?
Genetic testing for the PDK3 gene may be worth considering if you or close relatives have an inherited nerve condition with slowly worsening weakness, numbness, foot shape changes, or trouble walking. It can help confirm whether PDK3 is the cause and clarify the chance of passing it on in families.
A genetic result is only one part of your health story
A genetic result may offer valuable insight, although how much it reveals depends on the condition and the kind of variant involved. Lifestyle, environment, age, and medical history, among other factors, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best viewed alongside other parts of care. In other situations, that result may give a clear answer. In areas like medication response, genetic findings can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly than others, so the same treatment may work differently from one person to the next. This is a common part of human biology and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects. Other factors, including age, liver and kidney function, and other medicines, also play a part.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medications. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the PDK3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any concerns about symptoms, family history, side effects, or how medicines may affect you are best discussed with your doctor.
History
In the 1990s, researchers began sorting the pyruvate dehydrogenase kinase family into separate genes, including the PDK3 gene. This early work helped clarify that closely related genes could still have distinct roles in human biology. A key milestone came in the early 2010s, when variants in the PDK3 gene were linked to an inherited nerve condition in some families with X linked Charcot-Marie-Tooth disease. From these first observations, research expanded steadily. That discovery gave the gene a clearer place in medical genetics and helped connect family patterns of weakness and walking difficulty with a specific inherited cause. Since then, PDK3 has remained a niche but important gene in studies of inherited neuropathy.